Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 5/20 | 0.51 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715236 | 0.92 | LMNA (0.54) | CYP3A4LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10149033 | 0.89 | SMN1; SMN2 (0.55) | CYP3A4LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10149053 | 0.89 | LMNA (0.60) | CYP3A4LMNAACHEPARP1ALDH1A1 | |
| SCHEMBL21225979 | 0.86 | ALOX5 (0.57) | CYP3A4LMNAACHEPARP1 | |
| SCHEMBL1561685 | 0.86 | CYP3A4 (0.56) | CYP3A4LMNAACHEPARP1PTGS2 | |
| SCHEMBL13314605 | 0.85 | ALDH1A1 (0.55) | CYP3A4LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7613234 | 0.85 | CYP3A4 (0.54) | CYP3A4LMNAACHEPARP1CNR2 | |
| SCHEMBL27348013 | 0.85 | ACHE (0.70) | CYP3A4LMNAACHEPARP1 | |
| SCHEMBL717987 | 0.84 | NPC1 (0.65) | LMNANPC1RAB9ASMN1; SMN2BACE1 | |
| SCHEMBL717746 | 0.83 | GABRA1 (0.54) | CYP3A4NPC1RAB9ASMN1; SMN2BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-10-06 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2012-03-01 | — | — | US | disclosed |
| EP-2391658-A1 | MOLECULARLY IMPRINTED POLYMERS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010085851-A1 | MOLECULARLY IMPRINTED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2010-08-05 | — | — | WO | disclosed |
| EP-0306411-A2 | Ethanone oximes | MITSUBISHI KASEI CORPORATION (JP) | 1989-03-08 | — | — | EP | disclosed |
| US-4579677-A | CONTAINING PHENOLIC COMPOUND, OIL, CARBONYL COMPOUND, POLYCYCLIC COMPOUND, ESTER, AND ALCOHOL | LEVER BROTHERS COMPANY (US) | 1986-04-01 | — | — | US | disclosed |
| US-4469848-A | POLISHES FOR FLOORS, FURNITURE AND WINDOWS | LEVER BROTHERS COMPANY (US) | 1984-09-04 | — | — | US | disclosed |
| US-4347153-A | PHENOL; ALDEHYDE OR KETONE; ESTER; ALCOHOL; POLYCYCLIC COMPOUND; VEGETABLE OR SYNTHETIC OIL, EXTRACT, RESIN | LEVER BROTHERS COMPANY (US) | 1982-08-31 | — | — | US | disclosed |
| US-4343783-A | FOR DEODORIZING SKIN OR HAIR | LEVER BROTHERS COMPANY (US) | 1982-08-10 | — | — | US | disclosed |
| US-4322308-A | Detergent product containing deodorant compositions | LEVER BROTHERS COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
| US-4304679-A | NON-SOAP DETERGENTS | LEVER BROTHERS COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
| US-4289641-A | FOR LAUNDERING FABRICS SUBSEQUENTLY WORN IN CONTACT OF SKIN AND SWEAT GLANDS, DEODORIZING | LEVER BROTHERS COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| US-4288341-A | SOAP CONTAINING LIBOXIDASE INHIBITOR | LEVER BROTHERS COMPANY (US) | 1981-09-08 | — | — | US | disclosed |
| US-4278658-A | PHENOLIC COMPOUNDS, OILS, ALDEHYDES, KETONES | LEVER BROTHERS COMPANY (US) | 1981-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160288090-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CYP3A4 780/4885LMNA 3479/4885NPC1 3562/4885 |
| US-20120052757-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CYP3A4 780/4885LMNA 3479/4885NPC1 3562/4885 |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CYP3A4 780/4885LMNA 3479/4885NPC1 3562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.